1. ABT‐199 (Venetoclax), a BH3‐mimetic Bcl‐2 inhibitor, does not cause Ca2+‐signalling dysregulation or toxicity in pancreatic acinar cells. (8th November 2018) Authors: Jakubowska, Monika A; Kerkhofs, Martijn; Martines, Claudio; Efremov, Dimitar G; Gerasimenko, Julia V; Gerasimenko, Oleg V; Petersen, Ole H; Bultynck, Geert; Vervliet, Tim; Ferdek, Pawel E Journal: British journal of pharmacology Issue: Volume 176:Number 22(2019) Page Start: 4402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗